The role STAT5 plays in erythroid and megakaryocyte development comes into play when assessing the side effects of suppressing STAT5 through various JAK inhibitor therapies now used for hematopoietic and autoimmune disorders. This evidence concerns the gene STAT5B and Autoimmunity.